These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 25714115)

  • 1. Spray-Dried Influenza Antigen with Trehalose and Leucine Produces an Aerosolizable Powder Vaccine Formulation that Induces Strong Systemic and Mucosal Immunity after Pulmonary Administration.
    Sou T; Morton DA; Williamson M; Meeusen EN; Kaminskas LM; McIntosh MP
    J Aerosol Med Pulm Drug Deliv; 2015 Oct; 28(5):361-71. PubMed ID: 25714115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physical and immunogenic stability of spray freeze-dried influenza vaccine powder for pulmonary delivery: comparison of inulin, dextran, or a mixture of dextran and trehalose as protectants.
    Murugappan S; Patil HP; Kanojia G; ter Veer W; Meijerhof T; Frijlink HW; Huckriede A; Hinrichs WL
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):716-25. PubMed ID: 23933147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of amino acid excipients on morphology and solid-state properties of multi-component spray-dried formulations for pulmonary delivery of biomacromolecules.
    Sou T; Kaminskas LM; Nguyen TH; Carlberg R; McIntosh MP; Morton DA
    Eur J Pharm Biopharm; 2013 Feb; 83(2):234-43. PubMed ID: 23183447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of protective immunity against H1N1 influenza A(H1N1)pdm09 with spray-dried and electron-beam sterilised vaccines in non-human primates.
    Scherließ R; Ajmera A; Dennis M; Carroll MW; Altrichter J; Silman NJ; Scholz M; Kemter K; Marriott AC
    Vaccine; 2014 Apr; 32(19):2231-40. PubMed ID: 24631078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison between spray drying and spray freeze drying to produce an influenza subunit vaccine powder for inhalation.
    Saluja V; Amorij JP; Kapteyn JC; de Boer AH; Frijlink HW; Hinrichs WL
    J Control Release; 2010 Jun; 144(2):127-33. PubMed ID: 20219608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influenza vaccine powder formulation development: spray-freeze-drying and stability evaluation.
    Maa YF; Ameri M; Shu C; Payne LG; Chen D
    J Pharm Sci; 2004 Jul; 93(7):1912-23. PubMed ID: 15176078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physicochemical characterization and water vapor sorption of organic solution advanced spray-dried inhalable trehalose microparticles and nanoparticles for targeted dry powder pulmonary inhalation delivery.
    Li X; Mansour HM
    AAPS PharmSciTech; 2011 Dec; 12(4):1420-30. PubMed ID: 22038473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a dried influenza whole inactivated virus vaccine for pulmonary immunization.
    Audouy SA; van der Schaaf G; Hinrichs WL; Frijlink HW; Wilschut J; Huckriede A
    Vaccine; 2011 Jun; 29(26):4345-52. PubMed ID: 21514345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Designing CAF-adjuvanted dry powder vaccines: spray drying preserves the adjuvant activity of CAF01.
    Ingvarsson PT; Schmidt ST; Christensen D; Larsen NB; Hinrichs WL; Andersen P; Rantanen J; Nielsen HM; Yang M; Foged C
    J Control Release; 2013 May; 167(3):256-64. PubMed ID: 23415813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary delivery of influenza vaccine formulations in cotton rats: site of deposition plays a minor role in the protective efficacy against clinical isolate of H1N1pdm virus.
    Bhide Y; Tomar J; Dong W; de Vries-Idema J; Frijlink HW; Huckriede A; Hinrichs WLJ
    Drug Deliv; 2018 Nov; 25(1):533-545. PubMed ID: 29451040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developments in the formulation and delivery of spray dried vaccines.
    Kanojia G; Have RT; Soema PC; Frijlink H; Amorij JP; Kersten G
    Hum Vaccin Immunother; 2017 Oct; 13(10):2364-2378. PubMed ID: 28925794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nano spray-dried pyrazinamide-L-leucine dry powders, physical properties and feasibility used as dry powder aerosols.
    Kaewjan K; Srichana T
    Pharm Dev Technol; 2016; 21(1):68-75. PubMed ID: 25331092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Manufacturing of High-Concentration Monoclonal Antibody Formulations via Spray Drying-the Road to Manufacturing Scale.
    Gikanga B; Turok R; Hui A; Bowen M; Stauch OB; Maa YF
    PDA J Pharm Sci Technol; 2015; 69(1):59-73. PubMed ID: 25691715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of adjuvants for a spray freeze-dried whole inactivated virus influenza vaccine for pulmonary administration.
    Patil HP; Murugappan S; de Vries-Idema J; Meijerhof T; de Haan A; Frijlink HW; Wilschut J; Hinrichs WL; Huckriede A
    Eur J Pharm Biopharm; 2015 Jun; 93():231-41. PubMed ID: 25896446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary delivery of an inulin-stabilized influenza subunit vaccine prepared by spray-freeze drying induces systemic, mucosal humoral as well as cell-mediated immune responses in BALB/c mice.
    Amorij JP; Saluja V; Petersen AH; Hinrichs WL; Huckriede A; Frijlink HW
    Vaccine; 2007 Dec; 25(52):8707-17. PubMed ID: 17996993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Design of Experiment (DoE) approach to optimise spray drying process conditions for the production of trehalose/leucine formulations with application in pulmonary delivery.
    Focaroli S; Mah PT; Hastedt JE; Gitlin I; Oscarson S; Fahy JV; Healy AM
    Int J Pharm; 2019 May; 562():228-240. PubMed ID: 30849470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the stability of a spray-dried tuberculosis vaccine candidate designed for dry powder respiratory delivery.
    Gomez M; McCollum J; Wang H; Bachchhav S; Tetreau I; Gerhardt A; Press C; Kramer RM; Fox CB; Vehring R
    Vaccine; 2021 Aug; 39(35):5025-5036. PubMed ID: 34256969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leucine enhances the dispersibility of trehalose-containing spray-dried powders on exposure to a high-humidity environment.
    Wang Z; Wang H; Vehring R
    Int J Pharm; 2021 May; 601():120561. PubMed ID: 33811968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation of a dry powder influenza vaccine for nasal delivery.
    Garmise RJ; Mar K; Crowder TM; Hwang CR; Ferriter M; Huang J; Mikszta JA; Sullivan VJ; Hickey AJ
    AAPS PharmSciTech; 2006 Mar; 7(1):E19. PubMed ID: 16584149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel dry powder influenza vaccine and intranasal delivery technology: induction of systemic and mucosal immune responses in rats.
    Huang J; Garmise RJ; Crowder TM; Mar K; Hwang CR; Hickey AJ; Mikszta JA; Sullivan VJ
    Vaccine; 2004 Dec; 23(6):794-801. PubMed ID: 15542204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.